Sonova stock gains slightly as Swiss hearing specialist trades near yearly highs

Published on 09/01/2026 at 18:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock edges higher on September 1, 2026, with the Swiss hearing care group trading close to its 52-week high on the SIX Swiss Exchange and showing solid dividend and earnings expectations for the current year.

An extreme macro photograph of a tiny transparent high-tech hearing aid device held between a thumb and forefinger, with a translucent shell revealing intricate microelectronics circuit board patterns, copper traces, micro-components and nano-scale precis — Sonova CH0012549785: Extreme Makro-Nahaufnahme eines winzigen Hi-Tech-Hörgeräts mit sichtbarer Mikroelektronik und transparentem Gehäuse, Illustration mit AI erstellt.

Sonova (ISIN CH0012549785) stock is trading modestly higher on the SIX Swiss Exchange on September 1, 2026, with the share quoted at 232.80 CHF at midday, up 0.3 percent from the opening level of 233.00 CHF according to finanzen.ch.

Stock holds near 52-week high in Swiss index

Market data compiled by finanzen.ch show that Sonova shares reached a 52-week high of 248.00 CHF on August 24, 2026, leaving the current price of 232.80 CHF about 6.53 percent below that peak and indicating that the stock remains close to the upper end of its yearly range within the Swiss SPI index.

The same finanzen.ch overview highlights a 52-week low of 163.00 CHF, recorded on March 23, 2026, meaning that Sonova stock would need to fall roughly 29.98 percent from the present level to revisit that trough, a span that illustrates the strong recovery the hearing care specialist has achieved over the past months.

Dividend and earnings expectations support valuation

According to a Sonova-focused news item on finanzen.ch, the dividend estimate for the current fiscal year stands at 4.80 CHF per share, slightly above the historical payout of 4.70 CHF per share for the previous year and pointing to an expected increase of about 2.1 percent in annual shareholder returns.

The same finanzen.ch report notes that analysts forecast earnings per share of 10.64 CHF for Sonova in 2027, which, when set against the present Swiss share price, implies a forward price-earnings multiple in the low twenties and helps explain why the market continues to assign a premium valuation to the company within the Swiss mid-cap segment.

Go deeper

Sonova stock and recent figures at a glance

For more details on Sonova stock performance and company news, you can access additional market data and background information via the dedicated Sonova topic page and the group's investor relations overview.

Sonova stock on ad-hoc-news.de Investor Relations

Hearing solutions portfolio underpins growth

Sonova Holding AG describes itself as a global provider of hearing care solutions, offering hearing instruments, cochlear implants and lifestyle-aligned audio products for children and adults across Europe, the Americas and the Asia Pacific region, as outlined in the company profile on Yahoo Finance.

The group's Hearing Instruments segment covers development and distribution of hearing aids and related devices under brands such as Phonak, Unitron and Hansaton, while also including audiological care services through retail networks like AudioNova and Geers, a breadth of operations that gives Sonova a diversified footing in the broader medical devices industry.

Stock price level as of latest close

On the over-the-counter US market, Sonova's American depositary receipt with the ticker SONVY closed at 57.29 USD on August 31, 2026, according to the Yahoo Finance quote overview, representing a 1.03 percent decline for that session and providing an additional reference point for international investors alongside the primary Swiss franc quotation on SIX Swiss Exchange.